Late Onset Thrombotic Microangiopathy in Kidney Transplants; Poor Outcome Despite Eculizumab Treatment.

Transpl Int · 2025 · PMC12684766 · PMID 41368132

Europe PMC DOI

hedged sentence

0.3600

closest p · 7.2× alpha

0.3600

boldest claim

The sentences

did not reach statistical significanceP = 0.36not close (p > 0.1)

There is a suggestion that later presentation with post-transplant TMA is associated with worse kidney graft survival subsequently but this difference did not reach statistical significance ( P = 0.36).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.